StemPoint Capital LP 13F Holdings
CIK 0001952142 · NEW YORK, NY
As of Sep 30, 2025, StemPoint Capital LP reported 80 positions worth $499.1M in its SEC Form 13F filing.
Top 25 holdings
| Security | Ticker | Sector | Shares | Value | % of portfolio |
|---|---|---|---|---|---|
| ROIVANT SCIENCES LTD | ROIV | Healthcare | 4,197,187 | $63.5M | 12.72% |
| UNIQURE NV | QURE | Healthcare | 522,155 | $30.5M | 6.11% |
| SCHOLAR ROCK HOLDING CORP | SRRK | Healthcare | 744,604 | $27.1M | 5.42% |
| IMMUNOVANT INC | IMVT | Healthcare | 1,839,580 | $25.7M | 5.14% |
| DENALI THERAPEUTICS INC | DNLI | Healthcare | 1,734,659 | $25.2M | 5.05% |
| SYNDAX PHARMACEUTICALS INC | SNDX | Healthcare | 1,466,205 | $21.1M | 4.22% |
| CENTESSA PHARMACEUTICALS PLC | CNTA | Healthcare | 827,885 |